Research to Prevent Blindness (RPB) provides major eye research funding to more than 50 leading scientific institutions in the U.S. and supports the work of hundreds of talented vision scientists engaged in a diverse range of disease-oriented research.
RPB is recognized for the leadership role it has played in many advances in the field of ophthalmology.
The number of people with visual impairment (VI) and blindness is increasing in the U.S. and around the world.
At the ARVO Inaugural Press Conference, three RPB-funded scientists pushing the boundaries of imaging, early detection, regeneration.
Study reveals a way to inhibit excessive growth of lymphatic vessels which contribute to organ transplant rejection, cancer metastasis, lymphatic obstruction, diabetes and hypertension.
Protein analysis can make diagnoses more accurate and treatments better targeted to individual patients.
Adults whose eyes are slow to adjust to the dark have a greater risk of developing age-related macular degeneration.
Some patients taking high doses of a cholesterol-lowering medication had complete resolution of lipid deposits in the dry form of age-related macular degeneration (AMD).
A finding that opens the door to improving retinal prosthetic devices, targeting treatments to restore damaged retinal circuits, and improving early detection of retinal diseases.
|General Info||Research Scientists & Grantees||Eye Care Specialists||Donors & Partners|